Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and Glomerulonephritis

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with Glomerulonephritis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooley, AJ; Frisbie, DD; Grauer, GF; Longhofer, SL1
Cooley, AJ; Culham, CA; Frisbie, DD; Grauer, GF; Johnson, HC; Longhofer, SL; Schultz, KT1

Other Studies

2 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and Glomerulonephritis

ArticleYear
Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs.
    American journal of veterinary research, 1992, Volume: 53, Issue:5

    Topics: Animals; Antibodies; Concanavalin A; Creatinine; Dog Diseases; Dogs; Glomerular Filtration Rate; Glomerulonephritis; Immune Complex Diseases; Kidney; Male; Proteinuria; Pyridines; Thromboxane B2; Thromboxane-A Synthase

1992
Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis.
    American journal of veterinary research, 1991, Volume: 52, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Concanavalin A; Dinoprostone; Disease Models, Animal; Dogs; Glomerular Filtration Rate; Glomerulonephritis; Immune Complex Diseases; Kidney; Kidney Glomerulus; Male; Pyridines; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase

1991